Sanzyme Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 7.68 Cr
as on 16-11-2024
- Company Age 55 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 37.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 237.14 Cr
as on 16-11-2024
- Revenue 98.20%
(FY 2023)
- Profit -97.76%
(FY 2023)
- Ebitda -27.87%
(FY 2023)
- Net Worth 2.85%
(FY 2023)
- Total Assets 4.42%
(FY 2023)
About Sanzyme
The Corporate was formerly known as Uni-Sankyo Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.68 Cr.
The company currently has active open charges totaling ₹37.00 Cr. The company has closed loans amounting to ₹237.14 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sanzyme Private Limited India are Sumit Jamad as CFO and Kona Murthy as Company Secretary. Subrahmanyaprasad Kompella, Dhruv Soman, Raunak Soman, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24235TG1969PTC001282
- Company No.
001282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 1969
- Date of AGM
19 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sanzyme Private Limited offer?
Sanzyme Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Sexual Wellness Products, Fertility Enhancer, Bird Food, Poultry & Animal Food, Fish Foods, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Probiotic And Prebiotic Drugs, Multi-strain Probiotic.
Who are the key members and board of directors at Sanzyme?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Jamad  | CFO | 24-Dec-2018 | Current |
| Kona Murthy | Company Secretary | 09-May-1996 | Current |
| Jay Soman | Managing Director | 01-Jun-2010 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raunak Soman | Director | 28-Sep-2021 | Current |
| Subrahmanyaprasad Kompella | Whole-Time Director | 27-Oct-2017 | Current |
| Dhruv Soman | Director | 11-Jun-2020 | Current |
| Surapaneni Rao | Director | 19-Aug-1992 | Current |
| Arun Akinepally | Director | 16-Mar-2012 | Current |
Financial Performance and Corporate Structure Insights of Sanzyme.
Sanzyme Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.2% increase. The company also saw a substantial fall in profitability, with a 97.76% decrease in profit. The company's net worth moved up by a moderate rise of 2.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanzyme?
In 2023, Sanzyme had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pridhvi Asset Reconstruction And Securitisation Company LimitedActive 17 years 8 monthsSurapaneni Rao is a mutual person
Sanzyme Biologics Private LimitedActive 8 years 3 monthsDhruv Soman, Raunak Soman and 2 more are mutual person
Plantus Private LimitedActive 14 years 6 monthsSubrahmanyaprasad Kompella and Jay Soman are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Nov 2016 | ₹37.00 Cr | Open |
Others Creation Date: 28 Nov 2016 | ₹46.54 Cr | Satisfied |
Citi Bank N.A. Creation Date: 15 Sep 2014 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Sanzyme?
Sanzyme has a workforce of 193 employees as of Sep 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanzyme, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanzyme's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
